Skip to main content

Amyotrophic lateral sclerosis: the metabolic pathway to slow the disease

What if amyotrophic lateral sclerosis (ALS) were also a metabolic disease? This is the question raised by a research team led by Chantelle Sephton, professor in the Faculty of Medicine at Université Laval and researcher at the CERVO Research Centre. Their work using a mouse model suggests that the way nervous system cells use energy contributes to the death of motor neurons in the brain and spinal cord.

Read the article on Ulaval Nouvelles